Pharmaceutical Intermediate Linzagolix CAS: 935283-04-8

• Customization: Available
• CAS No.: 935283-04-8
• Formula: C22h15f3n2o7s
• Model NO.: 935283-04-8
• EINECS: /
• Grade: /
• Function: /
• Usage: Cosmetic Raw Materials
• Raw Material: /
• Transport Machine: Ordinary Goods Truck
• Density: 1.6±0.1 g/cm3
• Boiling Point: N/a
• Flash Point: N/a
• Melting Point: N/a
• Transport Package: Drum
• Specification: 99%
• Trademark: Labeyod
• Origin: China

Product Description

Product Description

   
A novel potent gonadotropin-releasing hormone (GnRH) antagonist.
 
English alias :OBE2109; OBE2109; OBE-2109; Linzagolix; LinzagolixCAS; ZavegepantImpurity55; 3 - (5 - (2, 3 - difluoro - 6 - methoxybenzyl) foxy) - 2 - fluoro - 4 - methoxyphenyl) - 2, 4 - dioxo 1, 2, 3, 4 - tetrahydrothieno [3, 4 - d] pyrimidine - 5 -carboxylicacid; 3 - [5 - [(2, 3 - Difluoro - 6 - methoxyphenyl) methoxy] - 2 - fluoro - 4 - methoxyphenyl) - 1, 2, 3, 4 - tetrahydro - 2, 4 - dioxothieno pyrimidi [3, 4 - d] ne-Chemicalbook5-carboxylicacid; Thieno pyrimidine - 5 - [3, 4 - d] carboxylicacid, 3 - [5 - [(2, 3 - difluoro - 6 - methoxyphenyl) methoxy] - 2 - fluoro - 4 - methoxyphenyl) - 1, 2, 3, 4 - Tetrahydro - 2, 4 - dioxo -; KLH2109,endometriosis,KLH
2109,GnRHReceptor,Gonadotropinreleasinghormonereceptor,inhibit,uterinefibroids,KLH2109,Linzago lix,GNRHR,adenomyosis,OBE2109,Inhibitor,OBE-2109,OBE2109

Company Profile